“…It includes mapping drug, target protein, or parasite vaccine epitopes vs. information about cell https://mol2net-07.sciforum.net/ lines, assay organisms, host organisms, bacteria metabolic networks, and parasite spreading networks. [7][8][9][10][11][12] IFPTML has also been applied to NP systems considering NP structure and coating agents, NP synthesis conditions, loaded drug structure, co-therapy loaded drugs, assay conditions, etc. [5,6,13-15] Accordingly, in this work, the IFPTML model for DADNP systems design was developed, including AD and NP components at the same time.…”